Molecular epidemiology of carbapenem-resistant gram-negative bacilli in Ecuador

被引:0
|
作者
Soria-Segarra, Claudia [1 ,2 ,3 ,4 ]
Soria-Segarra, Carmen [1 ,5 ]
Molina-Matute, Marcos [6 ]
Agreda-Orellana, Ivanna [6 ]
Nunez-Quezada, Tamara [7 ]
Cevallos-Apolo, Kerly [8 ]
Miranda-Ayala, Marcela [9 ]
Salazar-Tamayo, Grace [10 ]
Galarza-Herrera, Margarita [11 ]
Vega-Hall, Victor [12 ]
Villacis, Jose E. [13 ]
Gutierrez-Fernandez, Jose [3 ,4 ,14 ]
机构
[1] Med Serv, Sosecali, Guayaquil 090308, EC, Ecuador
[2] Guayaquil Univ, Fac Med Sci, Guayaquil, Ecuador
[3] Univ Granada & ibs, Sch Med, Dept Microbiol, Granada, Spain
[4] Univ Granada & ibs, PhD Program Clin Med & Publ Hlth, Granada, Spain
[5] Univ Catolica Santiago Guayaquil, Sch Med, Dept Internal Med, Guayaquil, Ecuador
[6] Hosp Rio, Cuenca, Ecuador
[7] Hosp Inst Ecuatoriano Seguridad Social Dr Teodoro, Guayaquil, Ecuador
[8] Hosp Infectol Dr Jose Daniel Rodriguez Mariduena, Guayaquil, Ecuador
[9] Omni Hosp, Guayaquil, Ecuador
[10] Hosp Vozandez, Quito, Ecuador
[11] Hosp Eugenio Espejo, Quito, Ecuador
[12] Interhosp, Guayaquil, Ecuador
[13] Pontificia Univ Catolica Ecuador, Ctr Invest Salud Amer Latina CISeAL, Quito 17012184, Ecuador
[14] Hosp Virgen Nieves, Inst Biosanit Res Ibs, Dept Microbiol, Granada, Spain
关键词
Carbapenem resistance; Carbapenemase genes; Ecuador; Gram-negative bacilli; COLISTIN RESISTANCE; MULTIPLEX PCR; AMERICA;
D O I
10.1186/s12879-024-09248-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction Carbapenem-resistant gram-negative bacilli are a worldwide concern because of high morbidity and mortality rates. Additionally, the increasing prevalence of these bacteria is dangerous. To investigate the extent of antimicrobial resistance and prioritize the utility of novel drugs, we evaluated the molecular characteristics and antimicrobial susceptibility profiles of carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii in Ecuador in 2022.Methods Ninety-five clinical isolates of carbapenem non-susceptible gram-negative bacilli were collected from six hospitals in Ecuador. Carbapenem resistance was confirmed with meropenem disk diffusion assays following Clinical Laboratory Standard Institute guidelines. Carbapenemase production was tested using a modified carbapenemase inactivation method. Antimicrobial susceptibility was tested with a disk diffusion assay, the Vitek 2 System, and gradient diffusion strips. Broth microdilution assays were used to assess colistin susceptibility. All the isolates were screened for the bla KPC, bla NDM, bla OXA-48, bla VIM and bla IMP genes. In addition, A. baumannii isolates were screened for the bla OXA-23, bla OXA-58 and bla OXA-24/40 genes.Results Carbapenemase production was observed in 96.84% of the isolates. The bla KPC, bla NDM and bla OXA-48 genes were detected in Enterobacterales, with bla KPC being predominant. The bla VIM gene was detected in P. aeruginosa, and bla OXA-24/40 predominated in A. baumannii. Most of the isolates showed co-resistance to aminoglycosides, fluoroquinolones, and trimethoprim/sulfamethoxazole. Both ceftazidime/avibactam and meropenem/vaborbactam were active against carbapenem-resistant gram-negative bacilli that produce serin-carbapenemases.Conclusion The epidemiology of carbapenem resistance in Ecuador is dominated by carbapenemase-producing K. pneumoniae harbouring bla KPC. Extensively drug resistant (XDR) P. aeruginosa and A. baumannii were identified, and their identification revealed the urgent need to implement strategies to reduce the dissemination of these strains.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Carbapenem-Resistant Gram-Negative Bacterial Infections in Children
    Aguilera-Alonso, David
    Escosa-Garcia, Luis
    Saavedra-Lozano, Jesus
    Cercenado, Emilia
    Baquero-Artigao, Fernando
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
  • [32] Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli
    Zeng, Mei
    Xia, Jun
    Zong, Zhiyong
    Shi, Yi
    Ni, Yuxing
    Hu, Fupin
    Chen, Yijian
    Zhuo, Chao
    Hu, Bijie
    Lv, Xiaoju
    Li, Jiabin
    Liu, Zhengyin
    Zhang, Jing
    Yang, Wenjie
    Yang, Fan
    Yang, Qiwen
    Zhou, Hua
    Li, Xin
    Wang, Jianhua
    Li, Yimin
    Ren, Jian'an
    Chen, Baiyi
    Chen, Dechang
    Wu, Anhua
    Guan, Xiangdong
    Qu, Jieming
    Wu, Depei
    Huang, Xiaojun
    Qiu, Haibo
    Xu, Yingchun
    Yu, Yunsong
    Wang, Minggui
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2023, 56 (04) : 653 - 671
  • [33] High excess costs of infections caused by carbapenem-resistant Gram-negative bacilli in an endemic region
    Andres Vargas-Alzate, Carlos
    Felipe Higuita-Gutierrez, Luis
    Lopez-Lopez, Lucelly
    Vanessa Cienfuegos-Gallet, Astrid
    Jimenez Quiceno, Judy Natalia
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (04) : 601 - 607
  • [34] Carbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the Puzzle
    Gniadek, Thomas J.
    Carroll, Karen C.
    Simner, Patricia J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (07) : 1700 - 1710
  • [35] Phenotypic and Genotypic Characterization of Carbapenem-Resistant Gram-Negative Bacilli Pathogens from Hospitals in Ghana
    Codjoe, Francis S.
    Donkor, Eric S.
    Smith, Thomas J.
    Miller, Keith
    MICROBIAL DRUG RESISTANCE, 2019, 25 (10) : 1449 - 1457
  • [36] Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates
    Schultze, Tilman G.
    Ferstl, Philip G.
    Villinger, David
    Hogardt, Michael
    Bechstein, Wolf O.
    Gottig, Stephan
    Wichelhaus, Thomas A.
    Zeuzem, Stefan
    Trebicka, Jonel
    Waidmann, Oliver
    Welker, Martin-Walter
    Kempf, Volkhard A. J.
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [37] CLINICAL AND MOLECULAR EPIDEMIOLOGY OF GENTAMICIN AND TOBRAMYCIN RESISTANT GRAM-NEGATIVE BACILLI IN AN NICU
    JENSON, HB
    BALTIMORE, RS
    PEDIATRIC RESEARCH, 1986, 20 (04) : A398 - A398
  • [38] Prevalence of carbapenem-resistant gram-negative bacilli producing carbapenemase by modified carbapenem inactivation method in an educational hospital in Tehran
    Pourabdollah, Mihan
    Askari, Elham
    Mansoury, Leila
    Mansoury, Hamze
    IMMUNOPATHOLOGIA PERSA, 2023, 9 (01):
  • [39] Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli
    Gibson, Gabrielle A.
    Bauer, Seth R.
    Neuner, Elizabeth A.
    Bass, Stephanie N.
    Lam, Simon W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 431 - 436
  • [40] Treatments and Predictors of Mortality for Carbapenem-Resistant Gram-Negative Bacilli Infections in Malaysia: A Retrospective Cohort Study
    Abubakar, Usman
    Zulkarnain, Amni Izzati
    Rodriguez-Bano, Jesus
    Kamarudin, Norhidayah
    Elrggal, Mahmoud E.
    Elnaem, Mohamed Hassan
    Harun, Sabariah Noor
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (12)